中文简介
《高级研究期刊》(简称J. adv.res .)是一种应用/自然科学，具有跨学科活动的同行评审期刊。该杂志旨在通过在以下领域发表原创、高质量的研究论文，为全球应用研究和知识做出重大贡献:1)医学2)医药科学3)牙科4)物理疗法5)兽医基础和生物科学，如:生物学、分子生物学、生物技术、化学、物理、生物物理学、地质学、天文学、生物物理学和环境科学。7)数学、工程学、计算机科学和8)农业科学除了原创的研究文章，《高级研究期刊》还出版评论、迷你评论、案例报告、给编辑的信和评论，从而为有关科学前沿观点的报告和讨论提供了一个论坛。所有提交的论文都要经过严格的单盲同行评审程序。该杂志致力于通过快速、公正和严格的审查程序出版稿件。稿件一旦被接受，出版后可立即获得免费的在线开放访问，允许用户阅读、下载、复制、分发、打印、搜索或链接到全文，从而为广大读者提供便利。该杂志每年出版6次。
英文简介
Journal of Advanced Research (abbreviated as J. Adv. Res.) is an applied/natural sciences, peer-reviewed journal with interdisciplinary activity. The journal aims to make significant contributions to applied research and knowledge across the globe through publication of original, high-quality research articles in the following fields:1) Medicine2) Pharmaceutical Sciences3) Dentistry4) Physical Therapy5) Veterinary Medicine6) Basic and Biological Sciences such as: biology, molecular biology, biotechnology, chemistry, physics, biophysics, geology, astronomy, biophysics and environmental science.7) Mathematics, Engineering, and Computer Sciences and8) Agricultural ScienceIn addition to original research articles, Journal of Advanced Research publishes reviews, mini-reviews, case reports, letters to the editor, and commentaries, thereby providing a forum for reports and discussions on cutting edge perspectives in science. All submitted papers are subjected to strict single blind peer reviewing process. The Journal is committed to publishing manuscripts via a rapid, impartial, and rigorous review process. Once accepted, manuscripts are granted free online open-access immediately upon publication, which permits its users to read, download, copy, distribute, print, search, or link to the full texts, thus facilitating access to a broad readership. The journal is published 6 times per year.
近年期刊自引率趋势图
JCR分区
| JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
| Q1 | MULTIDISCIPLINARY SCIENCES | Q1 | 12.822 |
近年期刊影响因子趋势图
CiteScore数值
| CiteScore | SJR | SNIP | 学科类别 | 分区 | 排名 | 百分位 |
| 17.10 | 1.870 | 3.548 | 大类：Multidisciplinary 小类：Multidisciplinary | Q1 | 8 / 120 |
93% |
